magicmed.com Competitors

We are Compass, a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. We believe people living with mental health conditions deserve the possibility of a better future. Our initial focus is advancing COMP360, a proprietary, investigational synthetic psilocybin treatment being evaluated for treatment-resistant depression (TRD) and post-traumatic stress disorder (PTSD). Our goal is to advance treatments that move the field of psychiatry towards treatment options that offer rapid onset and sustained durability, with infrequent dosing. We’re driven by our purpose of unlocking pathways to be—opening futures filled with possibility. Together, we’re on an ambitious journey toward enabling people living with mental health conditions to find clarity through self-discovery. Every journey needs a Compass.

MindMed is now Definium Therapeutics, a rebrand that reflects our commitment to forging a new era of psychiatry by applying precision to psychedelic medicine. Follow our new page at the link below!

Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. India is an integral part of Lilly’s global footprint, contributing significantly to both local impact and global innovation. With an established presence in the country for over three decades, Lilly operates through three business entities in Gurgaon, Bengaluru, and Hyderabad. To better align our efforts and amplify our impact in India, we have implemented the ‘One India’ strategic framework. This approach brings all our entities under one vision, enabling seamless collaboration and reflecting our commitment to growth and innovation in India. Lilly in Gurgaon is present in India since 1993 and serves as a hub for our commercial operations. We drive the delivery of groundbreaking treatments across key therapeutic areas, including cardiometabolic health, oncology, and immunology. Through our pharmaceutical operations, we serve thousands of patients across the country, addressing critical health needs and improving patient outcomes. Lilly in Bengaluru stands as a critical global hub accelerating the development and delivery of innovative medicines through cross-functional collaboration and deep scientific expertise and enabling Lilly’s global success. The centre brings together capabilities from Lilly Research Laboratories, Commercial, and Tech@Lilly, enabling operational excellence and innovation at scale. Lilly in Hyderabad is poised to be a transformative force in our global strategy, driving innovation, efficiency, and growth. By leveraging advanced technologies such as automation, AI, software product engineering, and cloud computing, the centre is set to deliver cutting-edge solutions that will enhance our global operation. To learn more, visit https://www.lilly.com/in/